Article
MicroRNA‐106a induces multidrug resistance in gastric cancer by targeting RUNX3
7 Aug 2013
Abstract excerpt
Multidrug resistance (MDR) is the main barrier to the success of chemotherapy for gastric cancer (GC). miR-106a, which is highly expressed in GC, influences a variety of aspects of GC. However, the function of miR-106a in MDR of GC still remains unclear. In the present study, we found that miR-106a is elevated in MDR cell lines. miR-106a promotes chemo-resistance of GC cells, accelerates ADR efflux, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
